Karin Lori Andersson, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hepatitis B, Chronic | 3 | 2016 | 393 | 0.440 |
Why?
|
| Adenoma | 1 | 2021 | 2168 | 0.370 |
Why?
|
| Hepatitis A | 1 | 2010 | 133 | 0.360 |
Why?
|
| Diagnostic Techniques and Procedures | 1 | 2008 | 213 | 0.280 |
Why?
|
| Antiviral Agents | 2 | 2009 | 2978 | 0.260 |
Why?
|
| Travel | 1 | 2010 | 788 | 0.250 |
Why?
|
| Drug Monitoring | 1 | 2009 | 956 | 0.220 |
Why?
|
| Fibrosis | 1 | 2008 | 2026 | 0.200 |
Why?
|
| Colorectal Neoplasms | 1 | 2021 | 6754 | 0.200 |
Why?
|
| Liver Function Tests | 1 | 2020 | 528 | 0.170 |
Why?
|
| Vascular Fistula | 1 | 2019 | 50 | 0.170 |
Why?
|
| Colon, Sigmoid | 1 | 2019 | 118 | 0.160 |
Why?
|
| Intestinal Fistula | 1 | 2019 | 140 | 0.160 |
Why?
|
| Iliac Artery | 1 | 2019 | 364 | 0.150 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2008 | 2211 | 0.140 |
Why?
|
| Colonoscopy | 2 | 2021 | 1365 | 0.140 |
Why?
|
| Hepatitis C | 1 | 2006 | 1582 | 0.130 |
Why?
|
| Foreign Bodies | 1 | 2019 | 398 | 0.120 |
Why?
|
| Postnatal Care | 1 | 2014 | 235 | 0.110 |
Why?
|
| Abdominal Pain | 1 | 2019 | 1059 | 0.100 |
Why?
|
| Liver Diseases | 1 | 2020 | 1252 | 0.100 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2019 | 1130 | 0.100 |
Why?
|
| Aftercare | 1 | 2016 | 860 | 0.090 |
Why?
|
| Postpartum Period | 1 | 2016 | 1078 | 0.090 |
Why?
|
| Referral and Consultation | 2 | 2020 | 3527 | 0.090 |
Why?
|
| Sex Factors | 1 | 2021 | 10392 | 0.070 |
Why?
|
| Early Detection of Cancer | 1 | 2021 | 3070 | 0.070 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2012 | 740 | 0.070 |
Why?
|
| Pregnancy Complications, Infectious | 2 | 2016 | 2026 | 0.070 |
Why?
|
| Fatty Liver | 1 | 2012 | 728 | 0.070 |
Why?
|
| Liver | 1 | 2020 | 7470 | 0.060 |
Why?
|
| Cholesterol, LDL | 1 | 2012 | 2354 | 0.050 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2014 | 3014 | 0.050 |
Why?
|
| Yersinia pseudotuberculosis | 1 | 1999 | 27 | 0.040 |
Why?
|
| HIV Infections | 1 | 2006 | 16678 | 0.040 |
Why?
|
| Drug Administration Schedule | 1 | 2006 | 4929 | 0.040 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 1999 | 473 | 0.040 |
Why?
|
| Klebsiella pneumoniae | 1 | 2019 | 246 | 0.040 |
Why?
|
| Intestinal Perforation | 1 | 2019 | 252 | 0.040 |
Why?
|
| Immunologic Factors | 1 | 2006 | 1575 | 0.040 |
Why?
|
| Bacterial Outer Membrane Proteins | 1 | 1999 | 404 | 0.040 |
Why?
|
| Drug Therapy, Combination | 1 | 2006 | 6483 | 0.030 |
Why?
|
| Cost-Benefit Analysis | 1 | 2008 | 5385 | 0.030 |
Why?
|
| Radiography, Abdominal | 1 | 2019 | 537 | 0.030 |
Why?
|
| Humans | 10 | 2021 | 742088 | 0.030 |
Why?
|
| Hepatitis B Surface Antigens | 1 | 2016 | 305 | 0.030 |
Why?
|
| Health Care Costs | 1 | 2008 | 3203 | 0.030 |
Why?
|
| Computer Simulation | 1 | 2008 | 6191 | 0.030 |
Why?
|
| Observer Variation | 1 | 2020 | 2593 | 0.030 |
Why?
|
| Cell Adhesion Molecules | 1 | 1999 | 1599 | 0.030 |
Why?
|
| Angiography | 1 | 2019 | 1636 | 0.030 |
Why?
|
| Massachusetts | 2 | 2016 | 8662 | 0.030 |
Why?
|
| Incidence | 1 | 2010 | 20928 | 0.030 |
Why?
|
| United States | 2 | 2010 | 69693 | 0.030 |
Why?
|
| Multivariate Analysis | 2 | 2016 | 12242 | 0.030 |
Why?
|
| Consensus | 1 | 2020 | 2935 | 0.020 |
Why?
|
| Phosphoproteins | 1 | 1999 | 2440 | 0.020 |
Why?
|
| Diagnosis, Differential | 2 | 2019 | 12958 | 0.020 |
Why?
|
| Logistic Models | 2 | 2016 | 13403 | 0.020 |
Why?
|
| Female | 5 | 2021 | 379592 | 0.020 |
Why?
|
| Male | 4 | 2021 | 349538 | 0.020 |
Why?
|
| Risk Factors | 2 | 2020 | 72145 | 0.020 |
Why?
|
| Gastroenterology | 1 | 2014 | 534 | 0.020 |
Why?
|
| Quality of Life | 1 | 2008 | 12730 | 0.020 |
Why?
|
| Attitude of Health Personnel | 1 | 2020 | 3839 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 1999 | 5019 | 0.020 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2020 | 3915 | 0.020 |
Why?
|
| Neuropeptide Y | 1 | 1986 | 200 | 0.020 |
Why?
|
| Medulla Oblongata | 1 | 1986 | 243 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2020 | 15056 | 0.020 |
Why?
|
| Academic Medical Centers | 1 | 2014 | 2749 | 0.010 |
Why?
|
| Pregnancy | 2 | 2016 | 29087 | 0.010 |
Why?
|
| Middle Aged | 3 | 2020 | 213127 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2008 | 57683 | 0.010 |
Why?
|
| Epinephrine | 1 | 1986 | 793 | 0.010 |
Why?
|
| Adult | 4 | 2020 | 213712 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2016 | 7716 | 0.010 |
Why?
|
| Aged | 2 | 2012 | 162944 | 0.010 |
Why?
|
| Catenins | 1 | 1999 | 41 | 0.010 |
Why?
|
| Prognosis | 1 | 2020 | 29010 | 0.010 |
Why?
|
| Age Factors | 1 | 2016 | 18355 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2016 | 7276 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 1999 | 829 | 0.010 |
Why?
|
| Cardiovascular System | 1 | 1986 | 827 | 0.010 |
Why?
|
| Primary Health Care | 1 | 2014 | 4551 | 0.010 |
Why?
|
| Retrospective Studies | 2 | 2016 | 77098 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2019 | 20086 | 0.010 |
Why?
|
| Fluorescent Antibody Technique | 1 | 1999 | 2505 | 0.010 |
Why?
|
| Plasmids | 1 | 1999 | 2305 | 0.010 |
Why?
|
| Point Mutation | 1 | 1999 | 1624 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2016 | 40450 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2014 | 39004 | 0.010 |
Why?
|
| Adolescent | 1 | 2019 | 85649 | 0.010 |
Why?
|
| Young Adult | 1 | 2016 | 56350 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2012 | 53187 | 0.000 |
Why?
|
| Rats, Inbred WKY | 1 | 1986 | 158 | 0.000 |
Why?
|
| Cell Line | 1 | 1999 | 15994 | 0.000 |
Why?
|
| Macrophages | 1 | 1999 | 5655 | 0.000 |
Why?
|
| Synaptic Transmission | 1 | 1986 | 1179 | 0.000 |
Why?
|
| Time Factors | 1 | 1999 | 40054 | 0.000 |
Why?
|
| Rats | 1 | 1986 | 24265 | 0.000 |
Why?
|
| Animals | 1 | 1986 | 168561 | 0.000 |
Why?
|